HCM
LLY icon

Hollencrest Capital Management’s Eli Lilly LLY Stock Holding History

Hollencrest Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$922K Hold
768
– – 0.06% 167
2026
Q1 		$707K Buy
768
+21
+3% +$21.3K 0.03% 189
2025
Q4 		$803K Sell
747
-93
-11% -$88.9K 0.03% 179
2025
Q3 		$641K Sell
840
-27
-3% -$20.1K 0.02% 194
2025
Q2 		$676K Sell
867
-411
-32% -$319K 0.03% 161
2025
Q1 		$1.06M Buy
1,278
+10
+0.8% +$8.32K 0.05% 139
2024
Q4 		$979K Sell
1,268
-2,027
-62% -$1.68M 0.04% 149
2024
Q3 		$2.92M Buy
3,295
+1,952
+145% +$1.75M 0.12% 76
2024
Q2 		$1.22M Sell
1,343
-147
-10% -$118K 0.05% 126
2024
Q1 		$1.16M Sell
1,490
-1,891
-56% -$1.35M 0.05% 132
2023
Q4 		$1.97M Buy
3,381
+53
+2% +$30.9K 0.19% 72
2023
Q3 		$1.79M Sell
3,328
-4
-0.1% -$2.06K 0.2% 74
2023
Q2 		$1.56M Buy
3,332
+8
+0.2% +$3.35K 0.16% 79
2023
Q1 		$1.14M Buy
3,324
+1,224
+58% +$413K 0.12% 99
2022
Q4 		$768K Buy
2,100
+1,056
+101% +$374K 0.1% 119
2022
Q3 		$338K Buy
1,044
+111
+12% +$35.2K 0.04% 183
2022
Q2 		$302K Buy
933
+70
+8% +$21K 0.04% 208
2022
Q1 		$247K Buy
863
+20
+2% +$5.15K 0.02% 290
2021
Q4 		$233K Buy
+843
New +$214K 0.02% 313
2021
Q2 		– Sell
-1,649
Closed -$308K – 404
2021
Q1 		$308K Sell
1,649
-26
-2% -$5.09K 0.03% 262
2020
Q4 		$283K Hold
1,675
– – 0.03% 253
2020
Q3 		$248K Sell
1,675
-10
-0.6% -$1.55K 0.03% 250
2020
Q2 		$277K Buy
+1,685
New +$259K 0.04% 217
2019
Q2 		– Sell
-6,051
Closed -$785K – 328
2019
Q1 		$785K Hold
6,051
– – 0.11% 122
2018
Q4 		$700K Hold
6,051
– – 0.1% 127
2018
Q3 		$785K Hold
6,051
– – 0.11% 122
2018
Q2 		$516K Hold
6,051
– – 0.07% 161
2018
Q1 		$468K Hold
6,051
– – 0.06% 175
2017
Q4 		$511K Buy
6,051
+2,200
+57% +$187K 0.07% 164
2017
Q3 		$329K Buy
+3,851
New +$316K 0.05% 212
2016
Q4 		– Sell
-2,766
Closed -$222K – 354
2016
Q3 		$222K Sell
2,766
-3,648
-57% -$292K 0.03% 298
2016
Q2 		$505K Sell
6,414
-87
-1% -$6.55K 0.08% 186
2016
Q1 		$468K Sell
6,501
-484
-7% -$36.6K 0.08% 185
2015
Q4 		$589K Sell
6,985
-1,364
-16% -$113K 0.1% 168
2015
Q3 		$698K Sell
8,349
-2,725
-25% -$230K 0.12% 124
2015
Q2 		$925K Sell
11,074
-194
-2% -$14.8K 0.13% 117
2015
Q1 		$819K Buy
11,268
+1,705
+18% +$121K 0.11% 132
2014
Q4 		$660K Sell
9,563
-525
-5% -$35.4K 0.09% 157
2014
Q3 		$655K Sell
10,088
-170
-2% -$10.8K 0.09% 151
2014
Q2 		$638K Buy
10,258
+5,375
+110% +$321K 0.09% 154
2014
Q1 		$288K Buy
4,883
+223
+5% +$12.4K 0.04% 273
2013
Q4 		$238K Buy
+4,660
New +$233K 0.04% 274

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hollencrest Capital Management's LLY Position: Q2 2026 in Review

Hollencrest Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 768 shares worth $922K. The position accounts for 0.06% of the portfolio, ranked #167.

Hollencrest Capital Management first reported a position in LLY in Q4 2013 and has held it in 42 quarters since. The position peaked at $2.92M in Q3 2024. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hollencrest Capital Management held 768 shares of Eli Lilly worth $922K as of Q2 2026.
  • Hollencrest Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.06% of Hollencrest Capital Management's portfolio in Q2 2026, its #167 holding.
  • Hollencrest Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 42 quarters since.
  • Hollencrest Capital Management's Eli Lilly position peaked at $2.92M in Q3 2024.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.